Trasylol Law Firm

Trasylol (aprotinin injection), made by Bayer Healthcare Pharmaceuticals, is administered during artery graft bypass surgery to prevent excessive blood loss. Recent studies show that Trasylol is linked to higher risks of serious complications and side effects including kidney damage, strokes, heart attacks and degenerative brain disease. Those who have recieved Trasylol before heart surgery need to know the facts about this drug's side effects and how Doug Monsour's Trasylol Law Firm can help gain compensation for any injury or wrongful death claim.

Recent FDA Hearing

In September 2006, the FDA met to discuss Trasylol’s side effects, risks and benefits. Earlier this year, two studies pointed to high risks associated with Trasylol. Shortly after the FDA’s meeting, Bayer announced the results of another safety study of Trasylol. This study was ommitted in Bayer's presentation to the FDA , and Bayer was heavily criticized as a result. The preliminary findings from this new observational study of patients from a hospital database reported that use of Trasylol may increase the chance for death, serious kidney damage, congestive heart failure and strokes. The FDA is evaluating the new study, and recommends that healthcare providers who use Trasylol carefully monitor patients for the occurrence of toxicity, particularly to the kidneys, heart, or brain, and promptly report adverse event information to Bayer Pharmaceuticals and/or the FDA. Additionally, the FDA warned recently that doctors should consider limiting Trasylol use.

If you or a loved one was given Trasylol during surgery, contact the Trasylol lawyers at the Monsour Law Firm today to discuss your legal rights. Call us at 1-800-685-5765 or fill out our short online form and a representative will contact you right away.